跳至主要内容
临床试验/ACTRN12620001266954
ACTRN12620001266954尚未招募4 期

A multi-centre prospective randomised controlled trial to evaluate the efficacy and safety of a synthetic haemostatic gel (PuraStat) for bleeding prevention post endoscopic nasal surgery

RPA Institute of Academic Surgery0 个研究点目标入组 209 人开始时间: 2020年11月25日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
209

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Participants must meet all of the following criteria:
  • 1. Patients suffering from a condition requiring endoscopic nasal turbinate reduction either by powered submucosal resection or turbinectomy
  • 2. Patients undergoing a bilateral and symmetrical surgery

排除标准

  • Participants must not meet any of the following criteria:
  • 1. Patients undergoing an asymmetrical or unilateral procedure
  • 2. Patients undergoing a medial maxillectomy
  • 3. Patients on anticoagulation or dual antiplatelet therapy
  • 4. Patients with known coagulation system disorders
  • 5. Patients suffering from spontaneous nasal bleeding
  • 6. Patients with intra-operative arterial bleeding
  • 7. Patients believed to have an allergic response to RADA 16 or oxidised regenerated cellulose
  • Patients who required return to theatre and further haemostasis to a site where PuraStat was applied in the first 24 hours will be excluded from the study population for secondary endpoint comparison

研究者

发起方
RPA Institute of Academic Surgery

相似试验

已完成
不适用
A prospective, randomised multicenter controlled trial on the treatment of intra-articular distal radius fractures; open reduction and internal fixation with volair angle stable plating versus percutaneous reduction and fixation in combination with an external fixatorwrist fracture10005944
NL-OMON31202Medisch Centrum Haaglanden148
尚未招募
3 期
A multicenter prospective randomized controlled trial: Comparison generic alginate Vs original alginate for symptoms controlled in the non-proton pump inhibitors responder GERDIn patients with gastroesophageal reflux disease, despite taking proton pump inhibitors But only 25.7% of symptoms could be controlled in 7 days and only 35.9% of GERD patients were found to have no heartburn symptoms over 28 days. Patients with GERD are chronic and affect their quality of life worse compared to normal people. which often affects sleep decreased vitality more pain in the body impaired sexual feelings and more anxiety.GERD
TCTR20230119007Dr. Kawin Tangvoraphonkchai162
尚未招募
Unknown
A multicenter prospective randomized controlled trial evaluating the usefulness of a real-time colonoscopy diagnostic support systemColorectal Neoplasms
JPRN-UMIN000051437Toho University Oomori hospital620
招募中
不适用
A multicenter prospective randomized controlled trial of the usefulness of RDI for injection in esophageal ESDsuperficial esophageal cancer
JPRN-UMIN000047475Keio University130
招募中
不适用
A multicenter prospective randomized controlled trial of pass through biliary stricture using a novel, flexible-tip, torquable, angled tip guidewire
JPRN-UMIN000029100niversity of Miyazaki90